Sandip I. Patel - Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AKTX on Nasdaq
All Insider Reports
All Insider Reports

Sandip I. Patel - trading volume in the past year for Akari Therapeutics Plc

Holdings reported by Sandip I. Patel for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 451,857 $506,080 $1.12 20 Mar 2025 Direct
Pre-Funded Warrants to purchase ADRs 154,664 $62,499 $0.4041 16 Dec 2025 Direct American Depositary Shares representing Ordinary Shares
Series A Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares 20,219 $22,645 $1.12 25 Apr 2025 Davis Island Ventures LLC
American Depositary Shares representing Ordinary Shares 19,880 $22,266 $1.12 25 Apr 2025 Quest Bio LLC
American Depositary Shares representing Ordinary Shares 13,901 $15,569 $1.12 20 Mar 2025 Innovative Lifesci Investment LLC
American Depositary Shares representing Ordinary Shares 6,250 $7,000 $1.12 25 Apr 2025 TT Insurance Investment LLC
Warrants to purchase American Depositary Shares ("ADRs") 247,462 16 Dec 2025 Direct American Depositary Shares representing Ordinary Shares
Stock Option (Right to Buy) 225,000 20 Mar 2025 Direct American Depositary Shares representing Ordinary Shares
Warrants to purchase ADRs 154,664 16 Dec 2025 Direct American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares 13,901 25 Apr 2025 Innovative Lifesci Investments LLC

Transactions reported by Sandip I. Patel for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.